nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—Emotional distress—Fluorouracil—pancreatic cancer	0.0401	0.0472	CcSEcCtD
Oxprenolol—Hypoglycaemia—Sunitinib—pancreatic cancer	0.0161	0.0189	CcSEcCtD
Oxprenolol—Cardiac failure—Sunitinib—pancreatic cancer	0.0161	0.0189	CcSEcCtD
Oxprenolol—Cardiac failure—Gemcitabine—pancreatic cancer	0.0129	0.0152	CcSEcCtD
Oxprenolol—Cardiac failure—Fluorouracil—pancreatic cancer	0.0127	0.0149	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.0118	0.0139	CcSEcCtD
Oxprenolol—Bradycardia—Sunitinib—pancreatic cancer	0.011	0.013	CcSEcCtD
Oxprenolol—Sweating increased—Irinotecan—pancreatic cancer	0.0109	0.0128	CcSEcCtD
Oxprenolol—Bronchospasm—Gemcitabine—pancreatic cancer	0.0107	0.0126	CcSEcCtD
Oxprenolol—Arthralgia—Tamoxifen—pancreatic cancer	0.00938	0.011	CcSEcCtD
Oxprenolol—Arthralgia—Erlotinib—pancreatic cancer	0.00928	0.0109	CcSEcCtD
Oxprenolol—Cardiac failure—Docetaxel—pancreatic cancer	0.00915	0.0108	CcSEcCtD
Oxprenolol—Bradycardia—Irinotecan—pancreatic cancer	0.00909	0.0107	CcSEcCtD
Oxprenolol—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00881	0.0104	CcSEcCtD
Oxprenolol—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00871	0.0103	CcSEcCtD
Oxprenolol—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.0087	0.0102	CcSEcCtD
Oxprenolol—Abnormal dreams—Epirubicin—pancreatic cancer	0.0082	0.00965	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.0082	0.00965	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.00815	0.0096	CcSEcCtD
Oxprenolol—Insomnia—Tamoxifen—pancreatic cancer	0.00814	0.00958	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00811	0.00955	CcSEcCtD
Oxprenolol—Insomnia—Erlotinib—pancreatic cancer	0.00805	0.00948	CcSEcCtD
Oxprenolol—Arthralgia—Sunitinib—pancreatic cancer	0.00804	0.00946	CcSEcCtD
Oxprenolol—Dyspepsia—Tamoxifen—pancreatic cancer	0.00792	0.00932	CcSEcCtD
Oxprenolol—Dyspepsia—Erlotinib—pancreatic cancer	0.00783	0.00922	CcSEcCtD
Oxprenolol—Fatigue—Tamoxifen—pancreatic cancer	0.00776	0.00913	CcSEcCtD
Oxprenolol—Fatigue—Erlotinib—pancreatic cancer	0.00767	0.00903	CcSEcCtD
Oxprenolol—Bronchospasm—Docetaxel—pancreatic cancer	0.00759	0.00893	CcSEcCtD
Oxprenolol—Abnormal dreams—Doxorubicin—pancreatic cancer	0.00758	0.00893	CcSEcCtD
Oxprenolol—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00754	0.00888	CcSEcCtD
Oxprenolol—Abdominal pain—Tamoxifen—pancreatic cancer	0.00711	0.00837	CcSEcCtD
Oxprenolol—Abdominal pain—Erlotinib—pancreatic cancer	0.00704	0.00828	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00702	0.00826	CcSEcCtD
Oxprenolol—Insomnia—Sunitinib—pancreatic cancer	0.00697	0.0082	CcSEcCtD
Oxprenolol—Dyspepsia—Sunitinib—pancreatic cancer	0.00678	0.00798	CcSEcCtD
Oxprenolol—Fatigue—Sunitinib—pancreatic cancer	0.00664	0.00782	CcSEcCtD
Oxprenolol—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00663	0.0078	CcSEcCtD
Oxprenolol—Asthenia—Tamoxifen—pancreatic cancer	0.00645	0.0076	CcSEcCtD
Oxprenolol—Arthralgia—Gemcitabine—pancreatic cancer	0.00645	0.00759	CcSEcCtD
Oxprenolol—Asthenia—Erlotinib—pancreatic cancer	0.00639	0.00752	CcSEcCtD
Oxprenolol—Pruritus—Tamoxifen—pancreatic cancer	0.00636	0.00749	CcSEcCtD
Oxprenolol—Pruritus—Erlotinib—pancreatic cancer	0.0063	0.00741	CcSEcCtD
Oxprenolol—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00621	0.00732	CcSEcCtD
Oxprenolol—Cardiac failure—Epirubicin—pancreatic cancer	0.00617	0.00726	CcSEcCtD
Oxprenolol—Hypoglycaemia—Epirubicin—pancreatic cancer	0.00617	0.00726	CcSEcCtD
Oxprenolol—Diarrhoea—Tamoxifen—pancreatic cancer	0.00615	0.00725	CcSEcCtD
Oxprenolol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00614	0.00722	CcSEcCtD
Oxprenolol—Abdominal pain—Sunitinib—pancreatic cancer	0.00609	0.00717	CcSEcCtD
Oxprenolol—Diarrhoea—Erlotinib—pancreatic cancer	0.00609	0.00717	CcSEcCtD
Oxprenolol—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00605	0.00713	CcSEcCtD
Oxprenolol—Diplopia—Epirubicin—pancreatic cancer	0.00602	0.00709	CcSEcCtD
Oxprenolol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00598	0.00704	CcSEcCtD
Oxprenolol—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00595	0.00701	CcSEcCtD
Oxprenolol—Dizziness—Tamoxifen—pancreatic cancer	0.00595	0.007	CcSEcCtD
Oxprenolol—Hypotension—Irinotecan—pancreatic cancer	0.00593	0.00698	CcSEcCtD
Oxprenolol—Dizziness—Erlotinib—pancreatic cancer	0.00589	0.00693	CcSEcCtD
Oxprenolol—Hypotension—Gemcitabine—pancreatic cancer	0.00578	0.0068	CcSEcCtD
Oxprenolol—Insomnia—Irinotecan—pancreatic cancer	0.00574	0.00676	CcSEcCtD
Oxprenolol—Cardiac failure—Doxorubicin—pancreatic cancer	0.00571	0.00672	CcSEcCtD
Oxprenolol—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00571	0.00672	CcSEcCtD
Oxprenolol—Hypotension—Fluorouracil—pancreatic cancer	0.00568	0.00669	CcSEcCtD
Oxprenolol—Hypersensitivity—Sunitinib—pancreatic cancer	0.00568	0.00668	CcSEcCtD
Oxprenolol—Headache—Tamoxifen—pancreatic cancer	0.00564	0.00663	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00563	0.00663	CcSEcCtD
Oxprenolol—Insomnia—Gemcitabine—pancreatic cancer	0.00559	0.00658	CcSEcCtD
Oxprenolol—Dyspepsia—Irinotecan—pancreatic cancer	0.00559	0.00658	CcSEcCtD
Oxprenolol—Headache—Erlotinib—pancreatic cancer	0.00558	0.00656	CcSEcCtD
Oxprenolol—Diplopia—Doxorubicin—pancreatic cancer	0.00557	0.00656	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00554	0.00652	CcSEcCtD
Oxprenolol—Asthenia—Sunitinib—pancreatic cancer	0.00553	0.00651	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.0055	0.00647	CcSEcCtD
Oxprenolol—Insomnia—Fluorouracil—pancreatic cancer	0.0055	0.00647	CcSEcCtD
Oxprenolol—Fatigue—Irinotecan—pancreatic cancer	0.00547	0.00644	CcSEcCtD
Oxprenolol—Pruritus—Sunitinib—pancreatic cancer	0.00545	0.00642	CcSEcCtD
Oxprenolol—Dyspepsia—Fluorouracil—pancreatic cancer	0.00535	0.0063	CcSEcCtD
Oxprenolol—Nausea—Tamoxifen—pancreatic cancer	0.00534	0.00629	CcSEcCtD
Oxprenolol—Fatigue—Gemcitabine—pancreatic cancer	0.00533	0.00627	CcSEcCtD
Oxprenolol—Nausea—Erlotinib—pancreatic cancer	0.00529	0.00622	CcSEcCtD
Oxprenolol—Diarrhoea—Sunitinib—pancreatic cancer	0.00527	0.00621	CcSEcCtD
Oxprenolol—Dizziness—Sunitinib—pancreatic cancer	0.00509	0.006	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00509	0.00599	CcSEcCtD
Oxprenolol—Abdominal pain—Irinotecan—pancreatic cancer	0.00502	0.00591	CcSEcCtD
Oxprenolol—Headache—Sunitinib—pancreatic cancer	0.00483	0.00568	CcSEcCtD
Oxprenolol—Palpitations—Docetaxel—pancreatic cancer	0.00475	0.00559	CcSEcCtD
Oxprenolol—Hypersensitivity—Irinotecan—pancreatic cancer	0.00468	0.0055	CcSEcCtD
Oxprenolol—Arthralgia—Docetaxel—pancreatic cancer	0.00458	0.00539	CcSEcCtD
Oxprenolol—Nausea—Sunitinib—pancreatic cancer	0.00458	0.00539	CcSEcCtD
Oxprenolol—Asthenia—Irinotecan—pancreatic cancer	0.00455	0.00536	CcSEcCtD
Oxprenolol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00448	0.00527	CcSEcCtD
Oxprenolol—Asthenia—Gemcitabine—pancreatic cancer	0.00444	0.00522	CcSEcCtD
Oxprenolol—Pruritus—Gemcitabine—pancreatic cancer	0.00437	0.00515	CcSEcCtD
Oxprenolol—Diarrhoea—Irinotecan—pancreatic cancer	0.00434	0.00511	CcSEcCtD
Oxprenolol—Pruritus—Fluorouracil—pancreatic cancer	0.0043	0.00506	CcSEcCtD
Oxprenolol—Thrombocytopenia—Docetaxel—pancreatic cancer	0.0043	0.00506	CcSEcCtD
Oxprenolol—Bradycardia—Epirubicin—pancreatic cancer	0.00424	0.00499	CcSEcCtD
Oxprenolol—Diarrhoea—Gemcitabine—pancreatic cancer	0.00423	0.00498	CcSEcCtD
Oxprenolol—Dizziness—Irinotecan—pancreatic cancer	0.0042	0.00494	CcSEcCtD
Oxprenolol—Diarrhoea—Fluorouracil—pancreatic cancer	0.00416	0.0049	CcSEcCtD
Oxprenolol—Hypotension—Docetaxel—pancreatic cancer	0.0041	0.00483	CcSEcCtD
Oxprenolol—Dizziness—Fluorouracil—pancreatic cancer	0.00402	0.00473	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.004	0.00471	CcSEcCtD
Oxprenolol—Headache—Irinotecan—pancreatic cancer	0.00398	0.00468	CcSEcCtD
Oxprenolol—Insomnia—Docetaxel—pancreatic cancer	0.00397	0.00467	CcSEcCtD
Oxprenolol—Bradycardia—Doxorubicin—pancreatic cancer	0.00392	0.00462	CcSEcCtD
Oxprenolol—Headache—Gemcitabine—pancreatic cancer	0.00387	0.00456	CcSEcCtD
Oxprenolol—Dyspepsia—Docetaxel—pancreatic cancer	0.00386	0.00455	CcSEcCtD
Oxprenolol—Headache—Fluorouracil—pancreatic cancer	0.00381	0.00448	CcSEcCtD
Oxprenolol—Fatigue—Docetaxel—pancreatic cancer	0.00378	0.00445	CcSEcCtD
Oxprenolol—Nausea—Irinotecan—pancreatic cancer	0.00377	0.00444	CcSEcCtD
Oxprenolol—Nausea—Gemcitabine—pancreatic cancer	0.00367	0.00432	CcSEcCtD
Oxprenolol—Nausea—Fluorouracil—pancreatic cancer	0.00361	0.00425	CcSEcCtD
Oxprenolol—Abdominal pain—Docetaxel—pancreatic cancer	0.00347	0.00408	CcSEcCtD
Oxprenolol—Hypersensitivity—Docetaxel—pancreatic cancer	0.00323	0.00381	CcSEcCtD
Oxprenolol—Palpitations—Epirubicin—pancreatic cancer	0.0032	0.00377	CcSEcCtD
Oxprenolol—Asthenia—Docetaxel—pancreatic cancer	0.00315	0.00371	CcSEcCtD
Oxprenolol—Pruritus—Docetaxel—pancreatic cancer	0.0031	0.00365	CcSEcCtD
Oxprenolol—Arthralgia—Epirubicin—pancreatic cancer	0.00309	0.00363	CcSEcCtD
Oxprenolol—Diarrhoea—Docetaxel—pancreatic cancer	0.003	0.00353	CcSEcCtD
Oxprenolol—Palpitations—Doxorubicin—pancreatic cancer	0.00296	0.00349	CcSEcCtD
Oxprenolol—Dizziness—Docetaxel—pancreatic cancer	0.0029	0.00342	CcSEcCtD
Oxprenolol—Thrombocytopenia—Epirubicin—pancreatic cancer	0.0029	0.00341	CcSEcCtD
Oxprenolol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00286	0.00337	CcSEcCtD
Oxprenolol—Arthralgia—Doxorubicin—pancreatic cancer	0.00286	0.00336	CcSEcCtD
Oxprenolol—Hypotension—Epirubicin—pancreatic cancer	0.00277	0.00326	CcSEcCtD
Oxprenolol—Headache—Docetaxel—pancreatic cancer	0.00275	0.00324	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.0027	0.00317	CcSEcCtD
Oxprenolol—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00268	0.00316	CcSEcCtD
Oxprenolol—Insomnia—Epirubicin—pancreatic cancer	0.00268	0.00315	CcSEcCtD
Oxprenolol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00265	0.00312	CcSEcCtD
Oxprenolol—Nausea—Docetaxel—pancreatic cancer	0.00261	0.00307	CcSEcCtD
Oxprenolol—Dyspepsia—Epirubicin—pancreatic cancer	0.0026	0.00307	CcSEcCtD
Oxprenolol—Hypotension—Doxorubicin—pancreatic cancer	0.00256	0.00301	CcSEcCtD
Oxprenolol—Fatigue—Epirubicin—pancreatic cancer	0.00255	0.003	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00249	0.00294	CcSEcCtD
Oxprenolol—Insomnia—Doxorubicin—pancreatic cancer	0.00248	0.00292	CcSEcCtD
Oxprenolol—Dyspepsia—Doxorubicin—pancreatic cancer	0.00241	0.00284	CcSEcCtD
Oxprenolol—Fatigue—Doxorubicin—pancreatic cancer	0.00236	0.00278	CcSEcCtD
Oxprenolol—Abdominal pain—Epirubicin—pancreatic cancer	0.00234	0.00275	CcSEcCtD
Oxprenolol—Hypersensitivity—Epirubicin—pancreatic cancer	0.00218	0.00257	CcSEcCtD
Oxprenolol—Abdominal pain—Doxorubicin—pancreatic cancer	0.00216	0.00255	CcSEcCtD
Oxprenolol—Asthenia—Epirubicin—pancreatic cancer	0.00212	0.0025	CcSEcCtD
Oxprenolol—Pruritus—Epirubicin—pancreatic cancer	0.00209	0.00246	CcSEcCtD
Oxprenolol—Diarrhoea—Epirubicin—pancreatic cancer	0.00202	0.00238	CcSEcCtD
Oxprenolol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00202	0.00237	CcSEcCtD
Oxprenolol—Asthenia—Doxorubicin—pancreatic cancer	0.00196	0.00231	CcSEcCtD
Oxprenolol—Dizziness—Epirubicin—pancreatic cancer	0.00196	0.0023	CcSEcCtD
Oxprenolol—Pruritus—Doxorubicin—pancreatic cancer	0.00194	0.00228	CcSEcCtD
Oxprenolol—Diarrhoea—Doxorubicin—pancreatic cancer	0.00187	0.00221	CcSEcCtD
Oxprenolol—Headache—Epirubicin—pancreatic cancer	0.00185	0.00218	CcSEcCtD
Oxprenolol—Dizziness—Doxorubicin—pancreatic cancer	0.00181	0.00213	CcSEcCtD
Oxprenolol—Nausea—Epirubicin—pancreatic cancer	0.00176	0.00207	CcSEcCtD
Oxprenolol—Headache—Doxorubicin—pancreatic cancer	0.00172	0.00202	CcSEcCtD
Oxprenolol—Nausea—Doxorubicin—pancreatic cancer	0.00163	0.00191	CcSEcCtD
Oxprenolol—SLC22A2—Metabolism—PRSS1—pancreatic cancer	0.000312	0.00207	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000307	0.00204	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CNR2—pancreatic cancer	0.000306	0.00203	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000306	0.00203	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—SCT—pancreatic cancer	0.000305	0.00203	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000301	0.002	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—SCT—pancreatic cancer	0.000298	0.00198	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRLHR—pancreatic cancer	0.000292	0.00194	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCK—pancreatic cancer	0.000291	0.00193	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRLHR—pancreatic cancer	0.000285	0.0019	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCK—pancreatic cancer	0.000285	0.00189	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CNR2—pancreatic cancer	0.000284	0.00188	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000284	0.00188	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000279	0.00185	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CNR2—pancreatic cancer	0.000277	0.00184	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000277	0.00184	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000277	0.00184	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000274	0.00182	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000274	0.00182	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000273	0.00181	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000271	0.0018	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ARG2—pancreatic cancer	0.000271	0.0018	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000268	0.00178	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000268	0.00178	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000266	0.00176	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00026	0.00173	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—SHH—pancreatic cancer	0.000254	0.00169	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IAPP—pancreatic cancer	0.000251	0.00167	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—SHH—pancreatic cancer	0.000249	0.00165	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SSTR3—pancreatic cancer	0.000248	0.00165	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DTX1—pancreatic cancer	0.000248	0.00165	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IAPP—pancreatic cancer	0.000246	0.00163	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—SST—pancreatic cancer	0.000243	0.00161	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SSTR3—pancreatic cancer	0.000243	0.00161	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DTX1—pancreatic cancer	0.000243	0.00161	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000241	0.0016	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000241	0.0016	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	0.000238	0.00158	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	0.000238	0.00158	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TYMP—pancreatic cancer	0.000237	0.00157	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000236	0.00157	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000236	0.00157	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PPY—pancreatic cancer	0.000233	0.00155	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	0.000233	0.00155	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	0.000229	0.00152	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PPY—pancreatic cancer	0.000228	0.00152	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000224	0.00149	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	0.000224	0.00149	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	0.000221	0.00147	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—SST—pancreatic cancer	0.000221	0.00147	CbGpPWpGaD
Oxprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00022	0.00146	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000219	0.00146	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	0.000216	0.00144	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	0.000216	0.00144	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	0.000216	0.00143	CbGpPWpGaD
Oxprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000215	0.00143	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	0.000212	0.00141	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	0.000208	0.00138	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	0.000208	0.00138	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000207	0.00137	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	0.000204	0.00135	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	0.000203	0.00135	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	0.000203	0.00135	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	0.000202	0.00134	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000202	0.00134	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000202	0.00134	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	0.000199	0.00132	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	0.000198	0.00131	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000198	0.00131	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	0.000197	0.00131	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	0.000195	0.00129	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	0.000192	0.00128	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GLP1R—pancreatic cancer	0.000191	0.00127	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	0.00019	0.00126	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	0.00019	0.00126	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—DPYD—pancreatic cancer	0.000188	0.00125	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000188	0.00125	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	0.000186	0.00124	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000183	0.00122	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	0.00018	0.0012	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	0.00018	0.0012	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—SLC2A2—pancreatic cancer	0.000178	0.00118	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	0.000176	0.00117	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	0.000176	0.00117	CbGpPWpGaD
Oxprenolol—SLC22A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000176	0.00117	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	0.000172	0.00114	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	0.000168	0.00112	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	0.000168	0.00111	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	0.000168	0.00111	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000167	0.00111	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	0.000165	0.00109	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	0.000164	0.00109	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	0.000164	0.00109	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000164	0.00109	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	0.000161	0.00107	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PRSS1—pancreatic cancer	0.000161	0.00107	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	0.00016	0.00106	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	0.000158	0.00105	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	0.000156	0.00104	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	0.000154	0.00102	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	0.00015	0.000998	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000149	0.000992	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	0.000148	0.000986	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	0.000147	0.000976	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	0.000146	0.00097	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	0.000145	0.000964	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	0.000142	0.000946	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	0.000142	0.000946	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	0.000139	0.000926	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	0.000139	0.000926	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ARG2—pancreatic cancer	0.000139	0.000925	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CD44—pancreatic cancer	0.000138	0.000916	CbGpPWpGaD
Oxprenolol—SLC22A2—Neuronal System—HRAS—pancreatic cancer	0.000135	0.000894	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GCG—pancreatic cancer	0.000132	0.000878	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SST—pancreatic cancer	0.00013	0.000865	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000129	0.000854	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	0.000128	0.000847	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SST—pancreatic cancer	0.000127	0.000847	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000127	0.000843	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000126	0.000835	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	0.000125	0.000828	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—STK11—pancreatic cancer	0.000124	0.000825	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000124	0.000825	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TYMP—pancreatic cancer	0.000122	0.000809	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	0.00012	0.000799	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	0.000118	0.000781	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000117	0.000775	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	0.000116	0.000771	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000114	0.000758	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	0.000114	0.000755	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000113	0.00075	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	0.000111	0.000736	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000111	0.000734	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	0.000109	0.000725	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	0.000108	0.00072	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—TYMS—pancreatic cancer	0.000107	0.00071	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	0.000107	0.000709	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000103	0.000681	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.0001	0.000667	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.85e-05	0.000654	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	9.82e-05	0.000652	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—DPYD—pancreatic cancer	9.66e-05	0.000641	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.63e-05	0.00064	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	9.56e-05	0.000635	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	9.46e-05	0.000629	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	9.35e-05	0.000621	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	9.34e-05	0.00062	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	9.26e-05	0.000615	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	9.16e-05	0.000609	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	9.13e-05	0.000607	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	8.94e-05	0.000594	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	8.75e-05	0.000581	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOE—pancreatic cancer	8.69e-05	0.000577	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	8.59e-05	0.000571	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	8.41e-05	0.000558	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	8.18e-05	0.000543	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	8e-05	0.000532	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	7.85e-05	0.000521	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	7.82e-05	0.00052	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	7.81e-05	0.000518	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	7.65e-05	0.000508	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	7.64e-05	0.000507	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	7.64e-05	0.000507	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARG—pancreatic cancer	7.57e-05	0.000503	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	7.48e-05	0.000497	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	7.47e-05	0.000496	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	7.32e-05	0.000486	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	7.12e-05	0.000473	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CD44—pancreatic cancer	7.1e-05	0.000471	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	7.05e-05	0.000468	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	6.96e-05	0.000462	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	6.9e-05	0.000458	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	6.9e-05	0.000458	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	6.89e-05	0.000458	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	6.89e-05	0.000458	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	6.81e-05	0.000453	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GCG—pancreatic cancer	6.8e-05	0.000452	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	6.74e-05	0.000448	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	6.74e-05	0.000448	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	6.67e-05	0.000443	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—STK11—pancreatic cancer	6.4e-05	0.000425	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	6.28e-05	0.000417	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	6.14e-05	0.000408	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	6.06e-05	0.000403	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	6.01e-05	0.000399	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	6e-05	0.000399	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—pancreatic cancer	5.96e-05	0.000396	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	5.93e-05	0.000394	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	5.93e-05	0.000394	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.87e-05	0.00039	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	5.8e-05	0.000386	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.5e-05	0.000365	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.45e-05	0.000362	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	5.33e-05	0.000354	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	5.28e-05	0.000351	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTEN—pancreatic cancer	5.19e-05	0.000345	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	5.17e-05	0.000343	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	5.08e-05	0.000337	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	5.04e-05	0.000335	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	4.97e-05	0.00033	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	4.93e-05	0.000328	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	4.9e-05	0.000326	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	4.86e-05	0.000323	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	4.8e-05	0.000319	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	4.75e-05	0.000316	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	4.73e-05	0.000314	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	4.68e-05	0.000311	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	4.63e-05	0.000307	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	4.59e-05	0.000305	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	4.58e-05	0.000304	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	4.56e-05	0.000303	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	4.49e-05	0.000298	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOE—pancreatic cancer	4.48e-05	0.000297	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	4.46e-05	0.000297	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	4.45e-05	0.000296	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	4.36e-05	0.000289	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	4.23e-05	0.000281	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	4.14e-05	0.000275	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	4.12e-05	0.000274	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	4.08e-05	0.000271	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	4.07e-05	0.00027	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	4.04e-05	0.000268	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	4.03e-05	0.000268	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	3.99e-05	0.000265	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	3.98e-05	0.000265	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.9e-05	0.000259	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	3.79e-05	0.000252	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	3.78e-05	0.000251	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	3.71e-05	0.000246	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	3.71e-05	0.000246	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	3.7e-05	0.000246	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	3.66e-05	0.000243	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	3.63e-05	0.000241	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.55e-05	0.000236	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	3.5e-05	0.000233	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	3.43e-05	0.000228	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	3.22e-05	0.000214	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	3.15e-05	0.000209	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	3.12e-05	0.000207	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.09e-05	0.000206	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.07e-05	0.000204	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	3.05e-05	0.000202	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—pancreatic cancer	2.99e-05	0.000199	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	2.98e-05	0.000198	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	2.91e-05	0.000194	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.67e-05	0.000178	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	2.63e-05	0.000175	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	2.57e-05	0.000171	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.89e-05	0.000125	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.54e-05	0.000102	CbGpPWpGaD
